Nicholas F. Evageliou, MD Nicholas F. Evageliou, MD, is an attending physician at CHOP’s Cancer Center with a special interest in kidney tumors in children, but with a broad clinical practice including liquid and solid tumors. Areas of Expertise: Kidney tumors Locations: Specialty Care & Surgery Center, Voorhees; Specialty Care, Princeton at Plainsboro Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467) Background I provide care for a broad range of oncology and hematology conditions in our suburban clinic in Voorhees, New Jersey. Our patients benefit from a small, approachable and welcoming clinic in a suburban setting that also is linked to the world-class medical expertise, clinical research and state-of-the-art facilities at Children's Hospital in Philadelphia. Our team spends a significant amount of time answering questions and explaining complicated treatments, and we work hard to provide treatment for almost all cancers treated at the main hospital in Philadelphia. While I maintain a clinical expertise with liquid tumors, my specific research interest is in solid tumors and kidney tumors in particular. My past research experience also includes work on neuroblastoma. Education and Training Medical SchoolMD - University of Connecticut School of Medicine, Farmington, CT InternshipPediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA ResidencyPediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA FellowshipHematology/Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA Board CertificationPediatric Hematology-OncologyPediatrics Titles and Academic Titles Attending PhysicianMedical Director, Hematology/Oncology Clinic, Specialty Care & Surgery Center, VoorheesAssociate Professor of Clinical Pediatrics in Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania Departments and Services Cancer Center Research Interests Kidney tumors Publications Papers2016 Evageliou NF, Haber M, Vu A, Laetsch TW, Murray J, Cheng NC, Liu X, Reese M, Corrigan KA, Vido M, Ziegler D, Hayes C, Pawel B, Marshall GM, Zhao H, Gilmour SK, Norris MD, Hogarty MD. Polyamine antagonist therapies prevent neuroblastoma initiation and lethal progression. Clin Cancer Res. 2016 Mar 24. pii: clincanres.2539.2015. [Epub ahead of print] BooksChapters Wallis E, Evageliou N. Neuroblastoma. In: Florin T, Ludwig S, editors. Netter's pediatrics. Philadelphia: Saunders Elsevier; 2011. Posters and PresentationsInvited Lectures 2016 An Approach to Common Anemias, Virtua Voorhees Practitioners, April 2016. 2015 Pediatric Oncology: Red Flags and When to Refer. Atlanticare Pediatrics Group, October 2015. Awards and Honors 2014-2015, South Jersey Magazine Top Docs for Kids Recognition 2002, Lyman M. Stowe Award, University of Connecticut 2001, Sylvia Bodak Memorial Scholarship Award, University of Connecticut 2000-2002, Hellenic Medical Society of New York Award and Scholarship 1998-2002, University of Connecticut Health Center Auxiliary Award Editorial and Academic Positions Academic and Institutional Committees 2015-present: AAP PREP Hematology/Oncology Editorial Board 2014-present, COG Renal Tumors Committee 2014-present, CHOP Intern Selection Committee Leadership and Memberships Memberships in Professional Organizations International 2006-present, Children’s Oncology Group - 2014, Member of Renal Tumors Committee National 2006-present, American Society of Pediatric Hematology and Oncology Patient Experience Ratings About the Patient Experience Rating System The Patient Experience Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.